Why supporting representative trial participation matters
Talking the talk
Related Posts
Government to adopt EU standards for high-risk diagnostic devices
New regulations aim to simplify processes and strengthen patient safety The Government is set to […]
NHS England secures access to new cystic fibrosis treatment ALYFTREK
Vertex’s once-daily triple therapy approved for eligible patients aged six and over Vertex Pharmaceuticals has […]
Genmab’s epcoritamab combination meets key endpoints in phase 3 lymphoma trial
Promising results support global submissions and priority review by US FDA Genmab has announced that […]